Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of Plasma Endostatin for Predicting Renal Outcome From Acute Kidney Injury Induced by Sepsis

NCT04633746 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT04633746
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04633746 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of Plasma Endostatin for Predicting Renal Outcome From Acute Kidney Injury Induced by Sepsis
Lead sponsor
Cairo University
Phase
Observational
Overall status
Completed
Start date
January 20, 2019
Completion date
August 31, 2020
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury due to sepsis